Generalized anxiety disorder was present in 28% of adult diabetic patients visiting a primary care clinic in Libya during the COVID-19 pandemic.
Cross-Sectional (n=115)
No
During the COVID-19 pandemic, 28% of adult diabetic patients at a primary care clinic in Libya experienced generalized anxiety disorder.
p-value: p=0.000
Aims To estimate the prevelance of Generalized anxiety disorder (GAD) in adult patients with diabetes mellitus (T1DM or T2DM) during COVID-19 pandemic. Method Random sample of 115 Adult Libyan patients (≥18 years) were drawn from 1200 Medical records of diabetic patients previously diagnosed in a primary care clinic (Gharyan polyclinic,South of Tripoli,West of Libya). Patients were recruited and diagnostically interviewed through outpatient visits and through Phone calls. Anxiety was assessed using Generalized Anxiety Disorder 7-item instrument (GAD-7), personal information, Co morbidities and History of COVID-19 infection within period of 3 weeks. Result The statistical analysis done by SPSS version 23, using ANOVA test. The GAD-7 scores ranged from 0 to 19 for the diabetic patient, 82 patients scores ranged from 0 to 4 with varying degrees of non-signifacant to subsyndromal symptopms of Generalized anxiety disorder, 24 patient with Mild GAD, 7 patients with moderate GAD and 2 patients with severe GAD. (P value = 0.000) Conclusion GAD is present in 28% of the patients who participated in the study. Additional epidemiological studies are needed to determine the prevalence of anxiety in the broader population of persons with diabetes.
Khrwat et al. (Tue,) conducted a cross-sectional in Diabetes mellitus (n=115). Diabetes mellitus during COVID-19 pandemic was evaluated on Prevalence of Generalized Anxiety Disorder (GAD) (p=0.000). Generalized anxiety disorder was present in 28% of adult diabetic patients visiting a primary care clinic in Libya during the COVID-19 pandemic.